Monopril and Osteoporosis - a phase IV clinical study of FDA data
Summary:
Osteoporosis is reported as a side effect among people who take Monopril (fosinopril sodium), especially for people who are female, 60+ old, also take Lipitor, and have High blood cholesterol.
The phase IV clinical study analyzes which people have Osteoporosis when taking Monopril. It is created by eHealthMe based on reports of 5,820 people who have side effects when taking Monopril from the FDA, and is updated regularly.
What is Monopril?
Monopril has active ingredients of fosinopril sodium. It is often used in high blood pressure. eHealthMe is studying from 5,910 Monopril users. Check the latest studies of Monopril.
What is Osteoporosis?
Osteoporosis (bones weak and more likely to break) is found to be associated with 1,808 drugs and 1,904 conditions by eHealthMe. Check the latest studies of Osteoporosis.
5,820 people reported to have side effects when taking Monopril.
Among them, 13 people (0.22%) have Osteoporosis.

Among these 13 people:
What is the gender of people who have Osteoporosis when taking Monopril? *
- female: 61.54 %
- male: 38.46 %
What is the age of people who have Osteoporosis when taking Monopril? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 50 %
- 60+: 50 %
What are other drugs people take besides Monopril? *
- Norvasc: 5 people, 38.46%
- Lipitor: 5 people, 38.46%
- Nexium: 4 people, 30.77%
- Prilosec: 4 people, 30.77%
- Neurontin: 3 people, 23.08%
- Plavix: 3 people, 23.08%
- Prozac: 3 people, 23.08%
- Fosamax: 3 people, 23.08%
- Zantac: 3 people, 23.08%
- Lasix: 2 people, 15.38%
What are other side effects people have besides Osteoporosis? *
- Fall: 4 people, 30.77%
- Depression: 4 people, 30.77%
- Back Pain: 4 people, 30.77%
- Weakness: 3 people, 23.08%
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 23.08%
- Oedema Peripheral (superficial swelling): 2 people, 15.38%
- Sinus Bradycardia (an unusually slow heartbeat due to heart disease): 2 people, 15.38%
- Cardiac Disorder: 2 people, 15.38%
- Diabetes: 2 people, 15.38%
- Oesophagitis (inflammation of oesophagus): 2 people, 15.38%
What are the existing conditions these people have? *
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 15.38%
- High Blood Cholesterol: 2 people, 15.38%
- Impaired Gastric Emptying: 1 person, 7.69%
- Hepatitis C: 1 person, 7.69%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.69%
- Gastric Disorder (disease of stomach): 1 person, 7.69%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 7.69%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Monopril and have Osteoporosis?
- Check whether Osteoporosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Monopril:
- Monopril (5,910 reports)
Osteoporosis treatments and more:
- Osteoporosis (290,734 reports)
How severe was Osteoporosis and when was it recovered:
Expand to all the drugs that have ingredients of fosinopril sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Monopril:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Osteoporosis:
- Osteoporosis (1,808 drugs)
Browse all the conditions that are associated with Osteoporosis:
- Osteoporosis (1,904 conditions)
Related publications that referenced our studies
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on fosinopril sodium (the active ingredients of Monopril) and Monopril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Xalatan and Sudden Death for Men aged 60+ - 2 seconds ago
- Xalatan and Death Sudden for Men aged 60+ - 3 seconds ago
- Xalatan and Death for Men aged 60+ - 3 seconds ago
- Drug interactions of Losartan and Rybelsus - 11 seconds ago
- Drug interactions of Ketalar and Lidocaine - 16 seconds ago
- Could Paracetamol cause Prostate Cancer? - 20 seconds ago
- Zestril vs. Sotalol Hydrochloride, side effect and effectiveness comparison - 51 seconds ago
- Could Avelox cause Hyperacusis? - 53 seconds ago
- Blood Fibrinogen Increased and drugs of ingredients of metronidazole - 54 seconds ago
- Drug interactions of Avelox and Duragesic-100 - a minute ago